Cellular clean-up can also sweep away forms of cancer

November 10, 2017 by Bill Hathaway
Cells untreated (left) or treated (right) with a PROTAC that degrades the target protein (green). Credit: Yale University

Two new research papers reinforce the benefits of a novel therapy that hijacks the cell's own protein degradation machinery to destroy cancer cells, Yale researchers report Nov. 9 in the journal Cell Chemical Biology.

The new approach to drug discovery, called Proteolysis Targeting Chimeras or PROTACs, was developed in the laboratory of Craig Crews, the Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology, professor of chemistry and pharmacology, as well as executive director of the Yale Center for Molecular Discovery.

The system engages the cell's own degradation machinery to destroy targeted proteins by tagging them for removal. Most drugs are based on the ability of small molecules to bind to and block the function of disease-causing proteins, but some proteins are resistant to such intervention.

"This system will help us change the current small-molecule drug paradigm that fails to target 75% of rogue proteins," said Crews, scientific founder of Arvinas LLC, the New Haven biotechnology company developing the concept.

The first paper shows for the first time that PROTAC system can target mutant RTK proteins, which have been linked to several forms of cancer. The second paper proves that the PROTAC system can target rogue proteins with greater specificity than traditional approaches.

Yale's George M. Burslem and Blake E. Smith are first authors of the first paper. Smith and Yale's Daniel P. Bondeson are co-first authors of the second paper.

Explore further: New type of drug can target all disease-causing proteins

More information: George M. Burslem et al. The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study, Cell Chemical Biology (2017). DOI: 10.1016/j.chembiol.2017.09.009

Daniel P. Bondeson et al. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead, Cell Chemical Biology (2017). DOI: 10.1016/j.chembiol.2017.09.010

Related Stories

New type of drug can target all disease-causing proteins

June 11, 2015

Current drugs block the actions of only about a quarter of known disease-causing proteins, but Yale University researchers have developed a technology capable of not just inhibiting, but destroying every protein it targets.

A kiss of death to drug the 'undruggable'

March 13, 2017

Scientists at the University of Dundee have reported a major breakthrough in targeting the causes of many diseases, using a `kiss of death' to destroy proteins which had previously been regarded as 'undruggable'.

Researchers target undruggable cancers

October 19, 2017

A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

Recommended for you

New technique could make captured carbon more valuable

December 15, 2017

Carbon capture could help the nation's coal plants reduce greenhouse gas emissions, yet economic challenges are part of the reason the technology isn't widely used today. That could change if power plants could turn captured ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.